Tuesday, October 13, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AHenry Schein names ITT CFO Emmanuel Caprais as new finance chieftodayBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift5 weeks agoDevices & TechKorean toxin makers split as Daewoong and Hugel advance4 days agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)5 weeks agoBusiness & M&AHugel chases 1 trillion won in three years5 days agoDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance5 weeks agoBusiness & M&AAbbVie takes $216M charge on Q3 deals, cuts earningslast weekDevices & TechECHOLASER X4 Clears FDA 510(k) for General Surgery4 weeks agoDevices & TechDEKA and GeoMedics expand laser portfolio across Indialast weekRegulatoryAllergan gets Health Canada nod for Boey, a fast-acting short-duration toxinlast weekDevices & TechBTL expands EXOMIND brain stimulation to OCD, adolescentslast weekDevices & TechSkinHealth Systems launches SkinStylus in six European marketslast week
Business & M&A

Henry Schein names ITT CFO Emmanuel Caprais as new finance chief

Emmanuel Caprais, who led ITT's financial operations for six years, takes over from Ronald South on November 4, 2026.

Close-up of two businessmen shaking hands outside, symbolizing partnership and agreement.
Photo: Ketut Subiyanto / Pexels
1-YEAR MOVE
+38% −1%
HSIC ▲37.6%
1-year price move by ticker
TickerCompany1-year change
HSICHenry Schein+37.6%

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Primary document: SEC 8-K: Henry Schein filed a material event · Filed: 2026-10-08

Henry Schein (NASDAQ: HSIC) announced a CFO transition on October 8, 2026, according to an SEC filing. Emmanuel Caprais, 51, will assume the role of Senior Vice President and Chief Financial Officer effective November 4, 2026, replacing Ronald N. South, who has held the position for four years and spent 18 years total at the distributor.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Caprais brings more than 25 years of global leadership experience, with a career spanning finance, operations, strategy, M&A, and investor relations.

Caprais comes from ITT Inc., a global industrial manufacturer where he spent six years as Senior Vice President and Chief Financial Officer, ending in May 2026. At ITT he led financial and capital allocation strategy, oversaw growth initiatives, and managed Financial Planning & Analysis and Investor Relations. Before that he held segment CFO roles across two of ITT's operating businesses. His earlier career included finance leadership positions at Magneti Marelli and Valeo in North America and Europe. He holds an MBA from Columbia Business School and an undergraduate degree from ESC Pau in France.

The transition will unfold in stages. Caprais begins as Senior Financial Advisor on October 12, 2026, allowing what the company calls a "structured transition and onboarding period. South remains CFO through November 3, 2026, including through the completion of the third quarter earnings process, then moves to Senior Advisor status.

Under his offer letter, Caprais will earn an annual base salary of $750,000 plus a target annual bonus of $750,000 under the company's Incentive Plan, subject to performance criteria set by the Compensation Committee. He receives a one-time cash sign-on bonus of $25,000, payable within 30 days of his start date, with repayment required if he leaves within one year.

His 2027 long-term incentive award is expected to have a grant date fair value of $2,500,000, to be granted in March 2027. He is also eligible for a one-time sign-on equity award in December 2026 valued at $250,000, split 50-50 between performance-based restricted stock units vesting on the third anniversary and time-based restricted stock units vesting ratably over four years. The company will also sponsor and pay up to $7,000 in fees and expenses for renewal of U.S. permanent resident cards for Caprais and his immediate family.

South receives severance payments and benefits under the company's amended and restated Executive Severance Plan, though the filing does not specify the amount.

CEO Frederick M. Lowery said Caprais's "ability to connect financial discipline with business execution will help us accelerate our value creation work. The company also announced plans to add two positions to its leadership team: a Chief Strategy and Transformation Officer and a new technology leadership role focused on AI implementation, data, and broader technology needs.

Henry Schein is a FORTUNE 500 company and S&P 500 member headquartered in Melville, New York, with operations in 34 countries and territories. The company reported sales of $13.2 billion in 2025, with compound annual growth of approximately 11 percent since going public in 1995. It serves more than 1 million customers globally through a network of 25,000 employees and distributes more than 300,000 branded and corporate products to dental and medical practitioners, laboratories, and institutional healthcare sites.

Business information, not medical or legal advice. Verify regulatory status at FDA.gov.

Source: original report ↗

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/henry-schein-names-itt-cfo-emmanuel-caprais-as-new-finance-chief/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →